Luminex Corporation (LMNX): Traded shares at $40.50 on Wednesday, August 05

0
28

Luminex Corporation (NASDAQ:LMNX) changes shares on Wednesday trading session, with a change of 2.71% or $1.07 shares. The trading starts at $41.69 and closed at $39.43 throughout the day. The trading session low price was $39.7531 and day high was $41.69 on Wednesday, August 05. After the session, the Healthcare sector daily volume shifted to 1.96 million while its average volume is 822.07K. In other hand, the LMNX market cap reached to $1.86B. While, its current target price is $33.33.

On June 29, 2020, BRIEF-Luminex Submits Emergency Use Authorization Request To U.S. FDA For Covid-19 Antibody Test. According to the news reported on Reuters, * LUMINEX SUBMITS EMERGENCY USE AUTHORIZATION REQUEST TO U.S. FDA FOR COVID-19 ANTIBODY TEST

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 12.53% and up 25.12% for month. Its quarterly performance was 5.06% above, while its half year performance is up 68.96%. LMNX yearly performance stood at positive 93.41% and rise 74.87% for year-to-date. Current recommendation for Luminex Corporation is 2.70.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. LMNX EPS (TTM) for 12-month is -0.29. EPS for this year is -190.70%, while for the next year its value is 0.40. Its EPS Q/Q reached -78.80%. It has an EPS of -17.60% down for past five years and for the next five years will be up 15.00%.

Let’s take a look on the analyst recommendations on LMNX for the current month and previous month. For the current month, 1 of 4 analysts recommend stock as Buy while 1 as Sell, 0 as overweight, 0 as underweight and 2 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings.

Blackrock Inc., Vanguard Group, Inc. (The) and RGM Capital, LLC are the top three holders in Luminex Corporation (LMNX) stock. On Mar 30, 2020, Blackrock Inc. has 7.26 million shares which valued 199.89 million. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 4.45 million shares which valued at 122.59 million. On Mar 30, 2020, RGM Capital, LLC has a total of 3.38 million shares which valued at 92.95 million. In the end, RGM Capital, LLC have 7.37% shares outstanding of Luminex Corporation (LMNX) on Mar 30, 2020. The insider ownership moved to 3.90% and institutional holding shifted to 87.10%.

The company posted an EPS (TTM) of -0.29. According to the most recent quarter report on (Sep 2020), 4 analysts estimated an average EPS of 0.12, while -0.12 EPS posted a year ago period. Analyst Estimated EPS for LMNX published in the report was -$0.06 – $0.24 during the same period. Comparing with last year, the average estimated EPS was -0.12 which is lower than 0.27 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for LMNX rise 49.38% for period of 200 days. SMA for 50 days was 24.08% which is showing green signal, while SMA-20 was 13.29%. The moving average value for Luminex Corporation (LMNX) is 29.79 and 33.55 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in LMNX stock. On Aug 05, SHAMIR NACHUM, President & CEO, sold 8,559 trading shares at the cost of $40.16, which valued at 0.34 million. On Aug 05, Rew Richard W. II, SVP, Gen Counsel & Corp Secy, sold 11,176 shares at the cost of $40.93, with total shares of 33,153. On Aug 04, SHAMIR NACHUM, President & CEO, sold 116,441 shares at the cost of 39.50. After this transaction, SHAMIR NACHUM total shares reached to 189,024 which valued at 4.6 million.